JURUPA VALLEY, CA - March 05, 2026 - PRESSADVANTAGE - Resurgence Alcohol & Drug Rehab Riverside has published a new ...
Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating addiction, and the field may be on the verge of obtaining desperately needed ...
LOS ANGELES, CA - March 04, 2026 - PRESSADVANTAGE - Muse Treatment Alcohol & Drug Rehab Los Angeles has published a ...
TAMPA, FL - March 05, 2026 - PRESSADVANTAGE - WhiteSands Treatment Center has released a new educational resource ...
Life House University doesn't offer a quick fix, but its approach is changing lives and helping to reunite parents with their ...
I don’t drink anymore. I don’t smoke anymore.” He might have shrugged it off, but reports accumulated in his clinic and ...
FORT LAUDERDALE, FL - January 22, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has released an educational ...
Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...
A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.
A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...
A London city councillor is calling on provincial regulators to take a look at the operations of New Dawn Medical, an addictions clinic that's partnered with five London pharmacies to distribute ...
My team and I set out to test whether GLP-1 drugs — medications like semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), originally developed for diabetes and then approved for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results